Torres, V. E., Higashihara, E., Devuyst, O., Chapman, A. B., Gansevoort, R. T., Grantham, J. J., . . . Czerwiec, F. S. (2016). Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial. Clin J Am Soc Nephrol.
シカゴスタイル引用形Torres, Vicente E., et al. "Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease By CKD Stage: Results From the TEMPO 3:4 Trial." Clin J Am Soc Nephrol 2016.
MLA引用形式Torres, Vicente E., et al. "Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease By CKD Stage: Results From the TEMPO 3:4 Trial." Clin J Am Soc Nephrol 2016.
警告: この引用は必ずしも正確ではありません.